Conference Programme

Thursday 23rd May 2019
6.00pm-8.00pm Ice Breaker Reception-Thistle Trafalgar Square, Whitcombe Street, WC2H 7HG

Friday 24th May 2019

Day One
9.00-9.30 Registration
9.30-9.35 Harry Cotterell – Welcome
9.35-9.40 Professor Angus Dalgleish – Introduction

Session One: Car-T cells immunotherapy, from T cells to ultimate adoptive immunotherapy
9.40-10.15 Carl June – CAR T cells Now and Then
10.15-10.30 TBC -Proferred Paper
10.30-11.00 TEA
11.00-11.20 Robert Hawkins – Update on T Cell therapy and Car T therapy

11.20-11.45 John Maher – T4 CAR T-cell immunotherapy of refractory head and neck cancer
11.45-12.00 TBC Proferred Paper
12.00-12.30 Speaker TBC
12.30-1.30pm Lunch & poster viewing

Session Two: How to enhance check point inhibitor activity
1.30-1.50 Raj Chopra – Small molecule modulators of antigen presentation
1.50-2.15 Speaker TBC
2.15-2.30 Samir Khleif – Reversing check point inhibition resistance
2.30-3.00 TEA
3.00-3.20 Rachel Zemek – Sensitisation of the tumour microenvironment to immune checkpoint blockade
3.20-3.35 Viktor Umansky – Targeting myeloid-derived suppressor cells in melanoma by low-dose chemotherapy
3.35-3.50 TBC – Proferred Paper
3.50-4.10 Natasha Brockwell – Impact of tumor inherent interferons on immune reactivity and personalized therapy in triple negative breast cancer
4.10-5.00 Discussion time

 

Saturday 25th May 2019

Day Two
Session Three: The role of Cannabinoids such as CBD, CBG etc in the enhancement of anticancer activity
9.00-9.15  Pan Pantziarka – title TBC
9.15-9.35  Marco Falasca – Use of Cannabinoids to enhance response to chemotherapy

9.35-9.55 Wai Lui  -Proferred Paper  – Overview on CBD
9.55-10.25 TEA
10.25-10.55 Roger Pertwee  -Novel potential therapeutic uses of certain plant and synthetic cannabinoids revealed by their pharmacological properties
10.55-11.05 Julian Kenyon  – Proferred Paper  – Clinical experience with pharma grade CBD on cancer patients
11.05-11.25 Wai Lui – Cannabinoids and Cancer
11.25-11.40 Vincenzo Bronte – Myeloid cell regulation of immunity
11.40-12.15 TBC
12.15-1.15 Lunch and poster viewing

Session Four: Vaccines and other Immunotherapies
1.15-1.35 Michael Shurin – New therapeutic targets: Tumor innervation
1.35-1.55 Bernard Fox  -Update on  personalised vaccine approachers
1.55-2.10 Robin Weiss – Proferred Paper
2.10-2.40 TEA
2.40-3.00 Paul Sondel – Activation of innate and adaptive immunity to induce an in situ vaccine
3.00-3.15 Lindy Durrant – TBC
3.15-3.45 Irving WeissmanHolbrook Kohrt Memorial Lecture – Normal and Neoplastic Stem Cells
3.45-4.00 Poster Prize Presentation
4.00-5.00 Angus Dalgleish – Collaboration session

7.00pm -10.00  Speakers’ Dinner, Royal Automobile Club (RAC)